SPECTRUM PHARMACEUTI...
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
SPECTRUM PHARMACEUTICALS INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 227 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker SPPIno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170481216
datesClosing price (adj.)
13.10.201713.36
11.10.201713.67
04.10.201714.70
27.09.201710.97
20.09.20179.94
13.09.201710.09
06.09.20179.95
30.08.20179.43
23.08.20179.40
16.08.20179.50
09.08.20179.15
02.08.20177.39
26.07.20177.87
19.07.20177.86
12.07.20177.41
05.07.20177.49
27.06.20177.56
20.06.20176.87
13.06.20176.49
06.06.20175.95
30.05.20175.60
23.05.20176.00
16.05.20176.02
09.05.20176.10
02.05.20177.53
25.04.20177.63
18.04.20176.39
11.04.20176.25
04.04.20176.49
28.03.20176.57
21.03.20176.42
14.03.20176.21
07.03.20176.31
28.02.20176.40
21.02.20175.84
14.02.20175.73
07.02.20174.96
31.01.20174.66
24.01.20174.65
17.01.20174.55
10.01.20174.64
03.01.20174.46
27.12.20164.55
19.12.20164.68
12.12.20164.44
05.12.20164.03
28.11.20164.10
21.11.20164.52
14.11.20164.79
07.11.20163.63
31.10.20163.54
24.10.20163.83
17.10.20163.99
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 13.36n/a
Market Capitalisation
in million USD
 1,074n/a
Enterprise Value
in million USD
 1,035n/a
Common Shares Outstanding
as per Apr 24, 2017
 80,412,251n/a
Preferred Shares Outstanding
as per Apr 24, 2017
 20n/a
Average Basic Shares Outstanding
TTM
 72,824,070n/a
Average Diluted Shares Outstanding
TTM
 76,055,511n/a
Index Membership
n/a
Business Summary
Spectrum Pharmaceuticals Inc is a biotechnology company in the United States. It develops drugs to cure serious diseases such as chemotherapy-induced neutropenia in patients with breast cancer.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 137n/a
Receivables 39n/a
Total Current Assets 197n/a
PP&E 0n/a
Total Assets 404n/a
Accounts Payable 48n/a
Current Debt 0n/a
Total Current Liabilities 57n/a
Long-Term Debt 99n/a
Total Liabilities 186n/a
Total Equity 217n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.20n/a
Other Ratios
Current Ratio 344.5%n/a
Liabilities to Equity Ratio 85.6%n/a
Debt to Assets Ratio 24.4%n/a
Profit & Loss StatementP&L data quality: 27% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
38
74
193
268
156
187
163
146
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-33
-78
-64
-97
-95
-121
-117
-121
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
5
-4
129
171
61
66
46
26
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-34
-49
-72
-90
-99
-97
-87
-87
Selling, General & Administrative
-34
-49
-72
-90
-99
-97
-87
-87
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
-29
-53
57
81
-39
-32
-41
-62
Non-Operating Income (Loss)
1
1
0
0
4
4
8
10
Interest Expense, net
0
0
0
0
2
9
9
9
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
1
1
0
0
1
-4
-1
1
Pretax Income (Loss), Adjusted
-28
-52
57
81
-35
-27
-33
-51
Abnormal Gains (Losses)
8
3
-3
0
-3
-1
-1
1
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-20
-49
53
81
-38
-28
-34
-51
Income Tax (Expense) Benefit, net
0
0
-4
14
-25
-2
0
2
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-20
-49
49
95
-63
-31
-34
-48
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-20
-49
49
95
-63
-31
-34
-48
Minority Interest
1
0
0
0
0
0
0
0
Net Income
-19
-49
49
95
-63
-31
-34
-48
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-19
-49
49
95
-63
-31
-34
-48
Remarks
restated on Mar 2, 2012 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Mar 12, 2014 n/a
calculated values,
restated on Mar 13, 2015 n/a
calculated values,
restated on Mar 14, 2016 n/a
calculated values,
restated on Mar 14, 2017 n/a
calculated values,
restated on Mar 14, 2017 n/a
calculated values,
restated on Mar 14, 2017 n/a
calculated values,
Balance SheetBS data quality: 58% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
96
161
143
160
133
140
158
Cash & Cash Equivalents
n/a
54
121
140
156
130
140
158
Short Term Investments
n/a
42
40
3
3
3
0
0
Accounts & Notes Receivable
n/a
21
52
92
49
71
30
40
Accounts Receivable, Net
n/a
21
52
92
49
71
30
40
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
4
11
14
14
9
4
9
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
1
2
15
12
9
16
10
Prepaid Expenses
n/a
1
2
3
3
4
4
4
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
12
2
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
8
5
13
6
Total Current Assets
n/a
122
226
265
235
222
191
217
Property, Plant & Equipment, Net
n/a
3
3
3
2
1
1
0
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
9
9
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
30
43
238
262
266
228
212
Intangible Assets
n/a
30
42
200
231
230
190
164
Goodwill
n/a
0
0
7
19
18
18
18
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
23
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
1
7
13
18
19
30
Total Noncurrent Assets
n/a
42
55
240
264
268
228
212
Total Assets
n/a
164
281
505
499
490
419
429
Liabilities and owners' equity
Payables & Accruals
n/a
42 42017000
57 56559000
110 110087000
87 86709000
93 93438000
65 64727000
61 61464000
Accounts Payable
n/a
39 38704000
55 54771000
105 105252000
80 79837000
85 84994000
57 56539000
52 52483000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
3 3313000
2 1788000
5 4835000
7 6872000
8 8444000
8 8188000
9 8981000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
21 21305000
22 21978000
13 13156000
3 3275000
16 16001000
12 11616000
4 4049000
Deferred Revenue
n/a
12 12300000
12 12300000
12 12300000
0 156000
10 9959000
6 6130000
3 3188000
Derivatives & Hedging
n/a
4 3904000
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
5 5101000
10 9678000
1 856000
3 3119000
6 6042000
5 5486000
1 861000
Total Current Liabilities
n/a
63 63322000
79 78537000
123 123243000
90 89984000
109 109439000
76 76343000
66 65513000
Long Term Debt
n/a
0 40000
0 9000
75 75000000
91 91480000
96 96298000
99 99377000
97 97043000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
26 25793000
14 14327000
18 18031000
36 36085000
30 29742000
30 30472000
30 30186000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
25 25495000
14 14029000
0 0
0 0
0 0
0 383000
0 323000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
7 7168000
7 6569000
7 6779000
7 6675000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 298000
0 298000
18 18031000
29 28917000
23 23173000
23 23310000
23 23188000
Total Noncurrent Liabilities
n/a
26 25833000
14 14336000
93 93031000
128 127565000
126 126040000
130 129849000
127 127229000
Total Liabilities
n/a
89 89155000
93 92873000
216 216274000
218 217549000
235 235479000
206 206192000
193 192742000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
385 384808000
453 452820000
464 463770000
518 518208000
539 538619000
552 552176000
640 640246000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
3 2926000
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-310 -310400000
-262 -261883000
-175 -175485000
-238 -237619000
-283 -283338000
-334 -334123000
-403 -402641000
Other Equity
n/a
0 -92000
0 -227000
0 273000
1 894000
-1 -850000
-5 -5319000
-2 -1579000
Equity Before Minority Interest
n/a
74 74316000
194 193636000
289 288558000
281 281483000
254 254431000
213 212734000
236 236026000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
74 74316000
194 193636000
289 288558000
281 281483000
254 254431000
213 212734000
236 236026000
Total Liabilities & Equity
n/a
163 163471000
287 286509000
505 504832000
499 499032000
490 489910000
419 418926000
429 428768000
Remarks restated on n/a restated on Mar 2, 2012 n/a restated on Feb 28, 2013 n/a restated on Mar 12, 2014 n/a restated on Mar 13, 2015 n/a restated on Mar 14, 2016 n/a restated on Mar 14, 2017 n/a restated on May 4, 2017 n/a
Cash Flow StatementCF data quality: 41% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-20
-49
50
94
-62
-46
-51
-69
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
4
5
6
12
22
25
32
26
Non-Cash Items
-9
-3
14
3
0
22
24
17
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
7
25
-26
-37
38
-5
1
-18
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
-18
-23
43
72
-2
-4
7
-43
Change in Fixed Assets & Intangibles
-1
-2
0
0
0
-1
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
26
-8
1
44
0
4
3
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-31
0
0
-133
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
-25
0
-1
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-6
-10
1
-89
0
-22
3
-1
Dividends Paid
0
0
0
-9
0
0
0
0
Cash From (Repayment of) Debt
0
0
25
-50
-168
0
0
-9
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
97
3
-3
-9
11
0
0
0
Increase in Capital Stock
97
0
0
0
13
0
0
0
Decrease in Capital Stock
0
0
-3
-9
-2
0
0
0
Other Financing Activities
-2
1
-3
123
189
-1
0
-5
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
95
4
18
55
32
-1
0
-14
Net Cash Before Disc. Operations and FX
71
-29
63
38
29
-27
10
-58
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
71
-29
63
38
29
-27
10
-58
Effect of Foreign Exchange Rates
0
0
0
0
-2
-2
-1
0
Net Changes in Cash
71
-29
63
38
27
-28
8
-58
Remarks
restated on Mar 2, 2012 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Mar 12, 2014 n/a
calculated values,
restated on Mar 13, 2015 n/a
calculated values,
restated on Mar 14, 2016 n/a
calculated values,
restated on Mar 14, 2017 n/a
calculated values,
restated on Mar 14, 2017 n/a
calculated values,
restated on Mar 14, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo